BTK and acute lymphoblastic leukemia: Downregulation of CD81 expression by aza/pano sensitizes acute lymphoblastic leukemia cells to chemotherapy and disrupts bruton tyrosine kinase (BTK) phosphorylation (Quagliano et al., 2020).